Dick has three decades of experience in building companies in healthcare and genomics, including 13 years at Baxter Laboratories. Subsequently to Baxter, Dick founded companies in both managed care and laboratory services, and was also the CEO of Visible Genetics (NASDAQ: VGIN), the pioneer in laboratory-based gene sequencing and bioinformatics. Education includes a BS in finance from New York University and an MBA from Harvard University.

Part of DNAnexus since its inception, George has been involved in the design and implementation of the DNAnexus product line, and its application in key accounts around the world. He is currently heading up strategic projects, exploring ways in which DNAnexus technology can be used to craft novel experiences that transcend traditional genomics boundaries. George holds a PhD in computer science from Stanford University, where he helped analyze 1% of the human genome as part of the ENCODE Pilot Project. His prior research experience includes comparative metagenomics, silicon compilers for reconfigurable hardware, and elliptic curve cryptanalysis.

Andrew works with a team of DNAnexus scientists on engagements with customers in clinical diagnostics, pharmaceutical R&D, and academia. He helped to run the largest cloud genomics project, conducted with the CHARGE Consortium and Baylor College of Medicine, covering 20,000 genomes/exomes, and the largest plant genomics project conducted thus far covering 3,000 rice genomes in the 3000 Rice Genomes Project. Through the work of the science team at DNAnexus, he has worked on clinical and research projects with SNP and indel calling in individuals and large cohorts, expression analysis, structural variant analysis, genome assembly, tumor-normal analysis, computational chemistry, and image processing. He received his PhD from Stanford University and his academic work involved comparative genomics in plants, proteomics, and machine learning.

Brady brings over 15 years experience as an innovator and leader in the life sciences space as well as the hospital ACO and consumer health and wellness industries. Prior to DNAnexus, Brady was head of strategy and market development for Illumina with a special focus on Informatics and driving opportunities to use genetics data as clinical utility. Brady serves on the board of multiple non-profit organizations including the Global Alzheimer's Association Interactive Network (GAAIN), Cancer Commons, Ci4CC, and is Co-Chair of the Advisory Board for the University of Washington Center for Commercialization (C4C). Brady is a graduate of University of Washington.

John is an experienced executive who is passionate about improving people's lives through innovative technology. Most recently, John was CPO at Vantiq delivering intelligent systems in the IoT space, and co-founder, CTO, and CPO at Model N (NYSE: MODN) where he led the Global Products group and drove the technical strategy. John earned a Bachelor of Science in Physics from the University of California at Irvine and a PhD in Physics from the Massachusetts Institute of Technology.

Fan works closely with prospects, customers, and the DNAnexus team to drive product vision and strategy. Fan joins DNAnexus from Adobe, where she served as Principal of Product Management responsible for cloud-based document productivity services. Prior to Adobe, she led Product Management at Model N, directly engaging with some of the world's largest pharmaceutical and biotechnology companies, including Merck and Amgen. Fan earned a Bachelor's degree in Biology at the University of Science and Technology of China, and a Ph.D. in Molecular Biology from the University of Southern California.

Kelly serves as the Head of People Operations where she leads DNAnexus' efforts in all things "people”. She is primarily responsible for talent acquisition, employee growth and development, building a great culture, and facilitating organizational development. Kelly joined DNAnexus after leading the HR efforts at Telenav, another disruptive technology company in Silicon Valley. There, Kelly led the HR efforts from venture-backed “start up” through a successful IPO. Kelly holds a Bachelor's in Psychology from Stonehill College.

Laura brings two decades of experience in developing and growing the accounting function and teams in high-tech startup companies. Laura comes most recently from Ingenuity Systems where she was the Controller during an acquisition by Qiagen, inc. Prior, Laura worked at companies from the initial startup stages through IPO. Laura holds a Bachelor of Science in Accountancy from Miami University.

Andrew is responsible for the company's overall business in Asia, Australia and New Zealand. Previously, Andrew has held senior positions at several cloud companies, including Sentient Technologies and Tendril. He was also responsible for business development, corporate development and strategy with Telstra and with Seagate Technology, where activities were focused broadly across the Asia Pacific region. Prior to that, he was a management consultant at the Boston Consulting Group. Andrew holds a BSc (Hons) from the University of Sydney and a Ph.D. from the University of California, Berkeley.

Mike leads R&D engineering, working with customers and partners to deploy cutting-edge software and algorithms enabling the translation of genomic data into precision medicine. He previously led cloud systems engineering during initial development of the DNAnexus Platform, after studying computational comparative genomics at MIT and the Broad Institute.

Tim brings over 20 years experience in enterprise software sales to the management team. He has built and led sales organizations and managed strategic customer relations within the life science and healthcare industries. At Oracle, Tim led the America's healthcare sales organization for the HSGBU, managed life science and translational research sales teams at ID Business Solutions, and held key bioinformatics sales and sales management positions at InforMax/Life Technologies. Tim holds a BA from the University of Colorado at Boulder.

Omar has decades of experience building global operations teams and infrastructures, including cloud computing at Amazon Web Services, social web real-time analysis services at Topsy Labs, and messaging and messaging security services at Cloudmark and Critical Path. Prior to joining DNAnexus, Omar developed the Enterprise I/T Cloud Transformation consulting practice at Amazon Web Services, working with global pharmaceutical, manufacturing, and entertainment companies to drive cloud adoption. Omar received his BS in Chemistry from UC Berkeley.

As Chief Medical Officer, David is responsible for driving clinical impact, working closely with management and engineering teams, and with external partners and collaborators. Most recently at Theravance Biopharma, David focused on strategy and business development, and led a product team. Prior, he was a management consultant at the Boston Consulting Group, and was an early member of the Department of Experimental Medicine at Merck Research Labs. He was also a founding advisor of Sage Bionetworks, and a co-founder of the MGH/MIT Center for Assessment Technology and Continuous Health (CATCH). David received his M.D. from the Harvard-MIT Division of Health, Science, and Technology at Harvard Medical School, and his Ph.D. from the Department of Biology at MIT. He trained in internal medicine and endocrinology at the Massachusetts General Hospital, and conducted his post-doctoral research in Doug Melton's lab at the Harvard Stem Cell Institute.

Brad brings over a decade of experience in corporate strategy, business development, capital raising and M&A in life sciences to DNAnexus. Most recently, Brad was a healthcare investment banker at MTS Health Partners executing over 25 diverse transactions accounting for $7B of M&A volume and capital raised. Prior, Brad worked in business development and strategic planning at Pfizer. Prior to that, as a strategy consultant, he advised biotech companies on strategic planning, commercialization and market development strategies at Frankel Group. Brad holds a BA from Penn and an MBA from Columbia Business School.